Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Clarivate (CLVT – Research Report) today and set a price target of $8.00.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: March 11 at 7:59:57 PM EDT Loading Chart for ICON ...